GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In INR
| Market Cap | 386.78B |
| Enterprise Value | 376.09B |
| P/E Ratio | 40.3 |
| PEG Ratio | 2.01 |
| Price/Sales Ratio | 11.11 |
| Price/Book Ratio | 24.57 |
| Enterprise/Revenue | 10.95 |
| Enterprise/EBITDA | 29.4 |
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0.28 |
| Operating Margin | 0.33 |
| Return On Assets | 0.29 |
| Return On Equity | 0.56 |
| Revenue | 38.22B |
| Revenue/Share | 245.48 |
| Gross Profit | 16.65B |
| EBITDA | 14.75B |
| Net Income | 10.36B |
| Diluted EPS | 61.15 |
| Total Cash | 22.19B |
| Total Cash/Share | 130.96 |
| Total Debt | 392.5M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 1.79 |
| Book Value Per Share | 111.04 |
| 52-Week Change | 10.15 |
| 52-Week High | 3,120.7 |
| 52-Week Low | 2,088.1 |
| Moving Average 50 Days | 2,684.19 |
| Moving Average 200 Days | 2,524.94 |
| Average Volume | 120,171 |
| Shares Outstanding | 169.41M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 57 |
| Trailing Annual Dividend Yield | 2.09 |
| Payout Ratio | 0.62 |
| Last Split Factor | 2:1 |
| Last Split Date | September 11, 2018 |